Peter Anderson
16Patents
6h-index
9Co-inventors
59Inventor score
Filing activity: Oct 28, 1992 → Dec 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5409698A | Liposome immunoadjuvants containing IL-2 | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5438075A | Oral glutamine to reduce stomatitis | Human Necessities | 14 | Expired |
| US5545668A | Oral glutamine to reduce stomatitis | Human Necessities | 13 | Expired |
| US5773006A | Lipsome containing IL-2 | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5650152A | Liposome immunoadjuvants containing IL-2 | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8703151B2 | Tuberculosis vaccines comprising antigens expressed during the latent infection phase | Chemistry; Metallurgy | 6 | Active |
| US6042829A | Biotherapy of cancer by targeting TP-3/P80 | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5690935A | Biotherapy of cancer by targeting TP-3/P80 | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10267788B1 | Linear peptides that mimic structural epitopes for antibody assays | Chemistry; Metallurgy | 1 | Active |
| US9011838B2 | Low/high dose probiotic supplements and methods of their use | Emerging Cross-Sectional Technologies | 0 | Active |
| US11884695B2 | Heavy vitamin B12 derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US9849144B2 | Glutamine and trehalose compositions | Human Necessities | 0 | Active |
| US10899789B2 | Heavy vitamin B12 derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US11597747B2 | Heavy vitamin B12 derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US12344630B2 | Novel, heavy vitamin B12 derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| USRE39485E1 | Oral Glutamine to reduce stomatitis | General | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.